Komal Jhaveri, MD, FACP - MSK Breast Oncologist & Early Drug Development Specialist
► OperationalLocation: 300 E 66th St Floors 1 - 4, New York, New York, United States — view on map
Komal Jhaveri, MD, FACP - MSK Breast Oncologist & Early Drug Development Specialist offers you comprehensive inpatient and outpatient medical services across multiple specialties in New York City, New York, United States.
Book Appointment Contact Provider Reviews
About the Oncology
How to book
- Click Book Appointment call +1 347-798-9722 .
- Use provider online portal: mskcc.org/cancer-care/doctors/komal-jhaveri.
Clinical team & doctors
No clinical team & doctors information available at the moment.
Patient reviews & ratings
No patient reviews available yet.
Reviews on Komal Jhaveri, MD, FACP - MSK Breast Oncologist & Early Drug Development Specialist
OnMend moderators take care of reviews trustiness. Each review submission is followed by check if it's real and worthy to publish.
All reviews submitted on this website are handled with strict privacy and are not shared with AI providers or used in any form of AI learning or training.
Start your review of Komal Jhaveri, MD, FACP - MSK Breast Oncologist & Early Drug Development Specialist.
Overall rating of Komal Jhaveri, MD, FACP - MSK Breast Oncologist & Early Drug Development Specialist on OnMend
N/A stars (no reviews)
Frequently Asked Questions about Komal Jhaveri, MD, FACP - MSK Breast Oncologist & Early Drug Development Specialist
Where is the Komal Jhaveri, MD, FACP - MSK Breast Oncologist & Early Drug Development Specialist situated at?
Komal Jhaveri, MD, FACP - MSK Breast Oncologist & Early Drug Development Specialist is situated at 300 E 66th St Floors 1 - 4, New York, New York, United States.
How can I book an appointment at Komal Jhaveri, MD, FACP - MSK Breast Oncologist & Early Drug Development Specialist?
You can book an appointment by clicking the "Book Appointment" button on this page or by calling the hospital directly.
Share on social media
Information last updated: November 8, 2024